EvoEndo Poised to Transform Clinical Endoscopy Practice with the EvoEndo® Single-Use Unsedated Transnasal Endoscopy (TNE) System

2022-04-18T23:33:43+00:00April 19th, 2022|Press Releases|

EvoEndo® Completes $8.4M Series A Financing to Initiate Rollout of the EvoEndo® Model LE Single-Use Gastroscope

EvoEndo Announces US FDA 510(k) Clearance for Single-Use Unsedated Transnasal Endoscopy (TNE) System

2022-04-13T18:17:35+00:00February 17th, 2022|Press Releases|

EvoEndo® has announced the receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) to begin marketing and sale of the EvoEndo® Single-Use Endoscopy System.

EvoEndo and Micro-Tech Endoscopy Announce Partnership for Single-Use Unsedated Endoscopy System

2022-04-13T18:10:50+00:00September 23rd, 2021|Press Releases|

EvoEndo® and Micro-Tech Endoscopy have signed a distribution agreement for the EvoEndo® Single-Use Endoscopy System, which eliminates the need for general anesthesia during routine endoscopic procedures.

EvoEndo Raises $10.1 Million to Make Unsedated Transnasal Endoscopy a Reality for Patients and Physicians

2022-04-13T18:02:46+00:00June 8th, 2021|Press Releases|

The funding round, which included a variety of family offices and early-stage life science investors, will be used to further EvoEndo’s innovative technology designed to help physicians diagnose, treat, and monitor conditions for a variety of gastrointestinal disorders.

Go to Top